Somasundaram R, Advani S H, Shetye M R, Gangal S G
J Clin Lab Immunol. 1986 Jan;19(1):43-7.
The effects of BM 12 531, a 2-cyanaziridinyl derivative, on in vitro generation of Con A induced suppressor cells as well as generation of spontaneous suppressor cells in peripheral blood lymphocytes of 9 chronic myeloid leukemia (CML) patients in remission, 9 patients with active Hodgkin's disease (HD) and 12 normal healthy donors were studied. The suppressor cells generated spontaneously and with Con A, in the presence and absence of the drug, were tested for their modulating effect on mitogenic (PHA) response of autologous lymphocytes. The results indicate that the addition of the drug at the time of generation of suppressor cells decreased the spontaneous suppressor cell activity in 2/4 healthy donors, 3/7 CML patients and 4/6 HD patients. Con A induced suppressor cell activity generated in presence of the drug was significantly reduced in 7/12 healthy donors, 6/9 CML patients and 3/9 HD patients.
研究了2-氰基氮丙啶衍生物BM 12 531对9例缓解期慢性粒细胞白血病(CML)患者、9例活动性霍奇金病(HD)患者和12名正常健康供体外周血淋巴细胞中伴刀豆球蛋白A(Con A)诱导的抑制细胞体外生成以及自发抑制细胞生成的影响。在有或无该药物的情况下,对自发产生以及用Con A诱导产生的抑制细胞针对其对自体淋巴细胞促有丝分裂(PHA)反应的调节作用进行了检测。结果表明,在抑制细胞生成时添加该药物可降低2/4名健康供体、3/7名CML患者和4/6名HD患者的自发抑制细胞活性。在该药物存在的情况下产生的Con A诱导的抑制细胞活性在7/12名健康供体、6/9名CML患者和3/9名HD患者中显著降低。